Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...

Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

William Blair is the premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to ...

PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and ...

William Blair is increasingly known for its prominence in the asset management business, with a global footprint of more than $81.9 billion¹ in client assets as of December 31, 2018.

William Blair has named Brent Gledhill as CEO. He will be succeeding John Ettelson, who has been appointed William Blair’s chairman. Gledhill joined William Blair as an investment banker in ...

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

William Blair has named Bryan P. Finkel and Eric G. Roddy as managing directors to its investment banking team. Both will focus on special purpose acquisition company transactions and be based in ...

"William Blair is a perfect strategic fit for ICM and our clients," said Mr. Heaphy in a news release. "Its investment-led, client-focused private partnership aligns strongly with ICM's culture.

Palo Alto Networks, Inc. (NASDAQ:PANW) is one of the best long term low volatility stocks to buy now. On July 16, William ...

William Blair wouldn’t immediately say how many total bankers it has currently, but that figure was 370 worldwide as of April 2019, so the reduction relative to that past banker headcount would ...